Prediction of changes in memory performance by plasma homovanillic acid levels in clozapine-treated patients with schizophrenia

By Sumiyoshi Tomiki   Roy A.   Kim C.-H.   Jayathilake K.   Lee M.   Sumiyoshi C.   Meltzer H.  

Psychopharmacology, Vol. 177, Iss. 1-2, 2004-12 ,pp. : 79-83

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetics of eicosapentaenoic acid in plasma and red blood cells after multiple oral dosing with icosapent ethyl in healthy subjects

By  

Clinical Pharmacology In Drug Development, Vol. 3, Iss. 2, 2014-03 ,pp. : 101-108

John Wiley & Sons Inc

Access to resources Recommend Favorite

Omega-3 fatty acid eicosapentaenoic acid. A new treatment for psychiatric and neurodegenerative diseases: a review of clinical investigations

By Song Cai   Zhao Shannon  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 10, 2007-10 ,pp. : 1627-1638

Informa Healthcare

Access to resources Recommend Favorite

Role of Polyunsaturated Fatty Acids and Fatty Acid Binding Protein in the Pathogenesis of Schizophrenia

By  

Current Pharmaceutical Design, Vol. 17, Iss. 2, 2011-01 ,pp. : 168-175

Bentham Science Publishers

Access to resources Recommend Favorite

Eicosapentaenoic acid inhibits vasopressin-activated Ca 2+ influx and cell proliferation in rat aortic smooth muscle cell lines

By Asano M.   Nakajima T.   Iwasawa K.   Asakura Y.   Morita T.   Nakamura F.   Tomaru T.   Wang Y.   Goto A.   Toyo-oka T.   Soma M.   Suzuki S.   Okuda Y.  

European Journal of Pharmacology, Vol. 379, Iss. 2, 1999-08 ,pp. : 199-209

Elsevier

Access to resources Recommend Favorite